Photo by Hit Stop Media from Shutterstock.com
- Contracting activity: Department of Health and Human Services
- Contract type: Firm-fixed-price contract
- Value: $20 million
- Contract date: September 6, 2022
The Department of Health and Human Services awarded AmerisourceBergen to allow Strategic National Stockpile to expand its distribution capacities of Monkeypox vaccines, treatments, and other related equipment. The contract boosted the delivery of medical countermeasures and prevented additional risks of infection.
AmerisourceBergen’s contract allowed the delivery capacity of up to 2,500 weekly shipments of frozen JYNNEOS vaccine and up to 2,500 weekly shipments of ambient temperature for TPOXX distribution. The products were offered free of charge to approximately five locations per jurisdiction.
5. DLA Finalized an Agreement to Provide Manufacturing Services under TRICARE West
Photo from TRICARE Official Website
- Contracting activity: Defense Logistics Agency
- Contract type: Firm-fixed price indefinite-delivery contract
- Value: $45 million
- Contract date: April 27, 2015
AmerisourceBergen was awarded a potential 10-year contract to support the TRICARE West Region. The company secured the prime vendor position for pharmacy under the Department of Defense. Work was expected for completion by December 30, 2025, with the potential ceiling value estimated at up to $1 billion.
6. HHS Secured a Contract for Warehousing and Storage of COVID-19 Treatment
Photo by Viacheslav Lopatin from Shutterstock.com
- Contracting activity: Office of Assistant Secretary for Preparedness and Response – HHS
- Contract type: Firm-fixed price contract
- Value: $57 million
- Contract date: October 30, 2020
AmerisourceBergen Drug Corporation signed a $57 million firm-fixed-price agreement with the Office of Assistant Secretary for Preparedness and Response, a part of the Department of Health and Human Services. The contract covered work for warehousing and storage services for COVID-19 treatment.
Since December 2020, AmerisourceBergen has partnered with reputable logistics companies to improve their supply chain of COVID-19 vaccines. With a collective distribution of 75 million doses worldwide, the pharmaceutical giant has helped more than 30 countries fight against the infection.
7. NIH Contracted Agreements for the Nationwide Allocation of Remdesivir to Hospitalized COVID-19 Patients
Photo by Tobias Arhelger from Shutterstock.com
- Contracting activity: National Institutes of Health
- Contract type: Firm-fixed price contract
- Value: $49 million
- Contract date: September 30, 2020
AmerisourceBergen Drug Corporation worked with the U.S. Department of Health and Human Services (HHS), the Office of the Assistant Secretary for Preparedness and Response (ASPR), and State Departments of Healthcare to allocate and procure Remdesivir. The drug was used primarily for the treatment of hospitalized COVID-19 patients.
AmerisourceBergen announced it had ceased the allocation for the COVID-19 treatment as the supply had been met. However, beginning on October 1, 2020, hospitals and healthcare providers could still purchase Remdesivir directly from AmerisourceBergen.
Frequently Asked Questions
What is AmerisourceBergen?
Photos from AmerisourceBergen Official Website
AmerisourceBergen is one of the largest manufacturers, suppliers, and distributors of animal and human services, including pharmaceutical products, services, and equipment. The company works with healthcare providers throughout the U.S. to provide world-class solutions to acute care hospitals, pharmacies, clinics, and other health-related facilities.
AmerisourceBergen is one of the largest pharmaceutical companies, handling more than 20% of all the pharmaceuticals sold and distributed in the U.S. and its territories. The company recorded an annual revenue of $200 billion, ranking the pharmaceutical giant 10th in the Fortune 500 company list.
Where is AmerisourceBergen headquarters?
AmerisourceBergen headquarters is located in Conshohocken, Pennsylvania, and was named one of the largest firms in the state. The company has over 30 DSCSA-compliant distribution centers and 1,300 other locations globally.
Who heads AmerisourceBergen?
AmerisourceBergen is headed by Steven H. Collis, serving as the Chairman, President, and Chief Executive Officer for more than 44,000 employees worldwide. The executives of the company partner with different agencies, such as the DoD and HHS, as well as commercial customers, such as Express Scripts, to support healthy and resilient communities.
What is the history of AmerisourceBergen?
AmerisourceBergen Drug Corporation traces its roots to The Brunswig Drug Company, established by Lucien Napoleon Brunswig in 1907. He had built years of trusted experience as one of the leading drug wholesalers in the industry since 1871 before founding the company, along with his various partners.
In 1969, Brunswig Drug Company was acquired by Bergen Drug Company, changing its name to Bergen Brunswig. In 2001, the company finalized its merger with AmeriSource Health Corporation, ultimately renaming it to AmerisourceBergen Drug Corporation.
In January 2023, AmerisourceBergen announced its intent to change its name to Cencora to create a shared identity among its employees and stronger brand loyalty, performance, and retention. The company plans to begin operation under Cencora by the second half of 2023.
Creating Healthier Futures and Moving Health Forward
Photo from AmerisourceBergen Official Website
AmerisourceBergen government contracts have improved the ability of the federal government to provide world-class healthcare nationwide. Having a sizable pharmaceutical business in the U.S. allows the company to move health forward and create healthier futures for human and animal health.